Skip to content

Venture

LOGO 5-01

Affiliations

Weill Cornell Medical College

Technologies

Therapeutic

Indication

Small molecular inhibitors of Rel/NF-kB

Additional Information

Women Founded

Our mission at ImmuneTarget is to develop novel Rel/NF-kB inhibitor drugs for cancer and autoimmune diseases.

ImmuneTarget, Inc. Team:

Hsiou-Chi Liou

Samedy Ouk